POSB197 Impact of Immune Checkpoint Inhibitors (ICIS) on the Management of Advanced Non-Small Cell Lung Cancer (NSCLC) in Real-World Practice at Karolinska University Hospital, Stockholm between 2012 and 2018

Autor: S Ekman, OT Brustugun, JB Sørensen, AM Kejs, Q Ann, M Bortolini, A Calleja, L Rosengren, P Huetson, MJ Daumont, JR Penrod, HC Jacobs, L Lacoin, H Koyi

Publikováno v: Value in Health. 25:S132-S133

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9eefce2a2dddfd4e4313503def25a8ca
https://doi.org/10.1016/j.jval.2021.11.635

Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trial.

Autor: Nymoen HM; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Alver TN; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway., Horndalsveen H; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Eide HA; Department of Oncology, Oslo University Hospital, Oslo, Norway., Bjaanæs MM; Department of Oncology, Oslo University Hospital, Oslo, Norway., Brustugun OT; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Section of Oncology, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Haakensen VD; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Helland Å; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Aug 01; Vol. 14, pp. 1412716. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project.

Autor: Mathian É; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; Department of Mathematics and Informatics, Ecole Centrale de Lyon, Lyon, France., Drouet Y; UMR CNRS 5558 LBBE, Claude Bernard Lyon 1 University, Villeurbanne, France; Prevention & Public Health Department, Centre Léon Bérard, Lyon, France., Sexton-Oates A; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Papotti MG; Department of Oncology, University of Turin, Turin, Italy., Pelosi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Vignaud JM; Department of Biopathology, Institut De Cancérologie de Lorraine (CHRU-ICL), Vandoeuvre-lès-Nancy, France; University Hospital of Nancy (CHRU), Nancy, France., Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Mansuet-Lupo A; Department of Pathology, Hôpital Cochin, AP-HP, Université de Paris, Paris, France., Damiola F; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Altun C; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Berthet JP; Department of Thoracic Surgery, FHU OncoAge, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Fournier CB; Caen Lower Normandy Tumour Bank, Centre François Baclesse, Caen, France., Brustugun OT; Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Centonze G; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chalabreysse L; Hospices Civils de Lyon, GHE, Institut de Pathologie Est, Bron, France., de Montpréville VT; Department of Pathology, Hôpital Marie-Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, France., di Micco CM; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Fadel E; Department of Pathology, Hôpital Marie-Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, France; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Université Paris-Saclay, Le Plessis-Robinson, France., Gadot N; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Graziano P; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Hofman P; FHU OncoAge, Biobank BB-0033-0025, Laboratory of Clinical and Experimental Pathology, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Hofman V; FHU OncoAge, Biobank BB-0033-0025, Laboratory of Clinical and Experimental Pathology, Nice Pasteur Hospital, University Cote d'Azur, Nice, France., Lacomme S; University Hospital of Nancy (CHRU), Nancy, France., Lund-Iversen M; Department of Pathology, Oslo University Hospital, Oslo, Norway., Mangiante L; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; School of Medicine, Stanford University, Stanford, USA., Milione M; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Muscarella LA; Unit of Oncology, Fondazione IRCCS Cas Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Perrin C; Hospices Civils de Lyon, GHE, Institut de Pathologie Est, Bron, France., Planchard G; Pathology Department, Caen University Hospital, Normandy University, Caen, France., Popper H; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Rousseau N; Caen Lower Normandy Tumour Bank, Centre François Baclesse, Caen, France., Roz L; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Sabella G; First Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tabone-Eglinger S; Biological Resource Center, Centre Léon Bérard, Lyon, France., Voegele C; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Volante M; Department of Oncology, University of Turin, Turin, Italy., Walter T; Service d'Oncologie Médicale, Groupement Hospitalier Centre, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France., Dingemans AM; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands., Speel EJ; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands., Derks J; Department of Pulmonary Diseases, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Girard N; Institut Curie, Versailles, France., Chen L; Department of Mathematics and Informatics, Ecole Centrale de Lyon, Lyon, France; Institut Universitaire de France (IUF), Paris, France., Alcala N; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France., Fernandez-Cuesta L; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Electronic address: fernandezcuestal@iarc.who.int., Lantuejoul S; Department of Biopathology, Centre Léon Bérard & Pathology Research Platform, Cancer Research Center of Lyon, Lyon, France., Foll M; Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Publikováno v: ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103591. Date of Electronic Publication: 2024 Jun 14.

Distribution and characteristics of malignant tumours by lung lobe.

Autor: Nilssen Y; Department of Registration, Cancer Registry of Norway, Box 5313 Majorstuen, Oslo, 0304, Norway., Brustugun OT; Section of Oncology, Vestre Viken Hospital Trust, Drammen, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Fjellbirkeland L; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Helland Å; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Møller B; Department of Registration, Cancer Registry of Norway, Box 5313 Majorstuen, Oslo, 0304, Norway., Wahl SGF; Department of Pathology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Solberg S; Department of Registration, Cancer Registry of Norway, Box 5313 Majorstuen, Oslo, 0304, Norway. stsg@kreftregisteret.no.; Department of Cardiothoracic Surgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway. stsg@kreftregisteret.no.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2024 Mar 04; Vol. 24 (1), pp. 106. Date of Electronic Publication: 2024 Mar 04.

Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people.

Autor: Nilssen Y; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Solberg S; Department of Registration, Cancer Registry of Norway, Oslo, Norway.; Department of Cardiothoracic Surgery, Rikshospitalet, Oslo University Hospital, Oslo, Norway., Brustugun OT; Section of Oncology, Vestre Viken Hospital Trust, Drammen, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Møller B; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Sundset A; Department of Pulmology, Rikshospitalet, Oslo University Hospital, Oslo, Norway., Wahl SGF; Department of Pathology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Helland Å; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2023 Jul 03; Vol. 64 (1).